Repligen (RGEN) Financials

$126.42 -0.84 (-0.66%)

As of 12:51 PM Eastern

Annual Income Statements for Repligen

This table shows Repligen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	9.35	221	28	17	21	60	128	186	36	-26
Consolidated Net Income / (Loss)	9.35	12	28	17	21	60	128	186	36	-26
Net Income / (Loss) Continuing Operations	9.35	221	28	17	21	60	128	186	36	-26
Total Pre-Tax Income	13	12	7.25	21	26	59	154	219	57	-27
Total Operating Income	14	16	14	26	36	70	167	225	48	-35
Total Gross Profit	48	162	74	108	151	210	391	456	278	275
Total Revenue	84	209	141	194	270	366	671	802	632	634
Operating Revenue	84	209	141	194	270	366	671	802	632	634
Total Cost of Revenue	35	47	67	87	119	157	279	346	354	360
Operating Cost of Revenue	35	47	67	87	119	157	279	346	354	360
Total Operating Expenses	35	-63	60	82	115	140	224	231	231	310
Selling, General & Admin Expense	25	31	52	66	96	120	184	216	219	263
Research & Development Expense	5.74	7.36	8.67	16	19	20	34	44	43	43
Other Special Charges / (Income)	4.08	3.24	-	-	-	-	5.87	-29	-31	3.19
Total Other Income / (Expense), net	-0.34	-4.28	-6.76	-4.55	-9.93	-11	-14	-5.53	9.00	8.08
Interest Expense	0.03	3.77	6.44	6.71	15	11	11	1.16	15	21
Interest & Investment Income	0.14	0.35	0.37	1.90	5.32	1.74	0.18	6.98	24	36
Other Income / (Expense), net	-0.45	-0.86	-0.69	0.26	-0.31	-1.58	-2.60	-11	0.05	-7.02
Income Tax Expense	4.08	0.01	-21	4.82	4.74	-0.71	25	33	21	-1.52
Basic Earnings per Share	$0.28	$0.35	$0.74	$0.38	$0.44	$1.14	$2.33	$3.35	$0.64	($0.46)
Weighted Average Basic Shares Outstanding	32.88M	33.57M	38.23M	43.77M	48.34M	52.55M	55.02M	55.46M	55.72M	55.94M
Diluted Earnings per Share	$0.28	$0.34	$0.72	$0.37	$0.44	$1.11	$2.24	$3.24	$0.63	($0.46)
Weighted Average Diluted Shares Outstanding	33.58M	34.10M	39.15M	45.47M	49.21M	53.89M	57.26M	57.46M	56.38M	55.94M
Weighted Average Basic & Diluted Shares Outstanding	33.40M	33.40M	38.30M	43.70M	52.08M	54.77M	55.33M	55.56M	55.77M	56.15M

This table shows Repligen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	40	49	15	20	17	-16	3.30	5.71	-0.65	-34
Consolidated Net Income / (Loss)	40	49	15	20	17	-16	3.30	5.71	-0.65	-34
Net Income / (Loss) Continuing Operations	40	49	15	20	17	-16	3.30	5.71	-0.65	-34
Total Pre-Tax Income	47	53	19	25	11	1.87	3.70	9.03	-1.15	-39
Total Operating Income	53	49	14	19	4.69	9.87	3.75	5.47	-7.83	-37
Total Gross Profit	114	96	84	80	37	78	77	82	77	39
Total Revenue	201	187	165	159	141	167	153	159	155	168
Operating Revenue	201	187	165	159	141	167	153	159	155	168
Total Cost of Revenue	87	91	82	79	105	88	76	77	77	129
Operating Cost of Revenue	87	91	82	79	105	88	76	77	77	129
Total Operating Expenses	62	47	70	61	32	69	73	76	85	75
Selling, General & Admin Expense	54	53	56	49	56	58	62	65	76	60
Research & Development Expense	10	11	12	9.71	11	10	11	11	9.71	12
Other Special Charges / (Income)	-2.31	-17	1.24	1.79	-34	0.70	0.00	0.00	0.00	3.19
Total Other Income / (Expense), net	-5.20	4.15	4.70	5.62	6.69	-8.01	-0.06	3.56	6.68	-2.11
Interest Expense	0.33	0.27	0.41	0.41	0.41	14	5.03	5.12	5.12	5.46
Interest & Investment Income	2.18	4.02	5.49	5.96	6.66	6.02	8.99	9.41	9.13	8.29
Other Income / (Expense), net	-7.05	0.40	-0.38	0.07	0.44	-0.08	-4.02	-0.74	2.68	-4.94
Income Tax Expense	7.06	4.26	3.22	5.12	-5.54	18	0.40	3.31	-0.50	-4.74
Basic Earnings per Share	$0.73	$0.87	$0.28	$0.36	$0.30	($0.30)	$0.06	$0.10	($0.01)	($0.61)
Weighted Average Basic Shares Outstanding	55.50M	55.46M	55.59M	55.71M	55.77M	55.72M	55.79M	55.88M	56.01K	55.94M
Diluted Earnings per Share	$0.71	$0.84	$0.27	$0.35	$0.30	($0.29)	$0.06	$0.10	($0.01)	($0.61)
Weighted Average Diluted Shares Outstanding	57.30M	57.46M	57.05M	56.86M	56.94M	56.38M	56.53M	56.43M	56.01K	55.94M
Weighted Average Basic & Diluted Shares Outstanding	55.52M	55.56M	55.68M	55.76M	55.83M	55.77M	55.88M	56.01M	56.03M	56.15M

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	19	68	51	20	341	180	-113	-80	228	6.03
Net Cash From Operating Activities	15	7.52	17	33	67	63	119	172	114	175
Net Cash From Continuing Operating Activities	15	7.52	17	33	65	58	119	172	114	175
Net Income / (Loss) Continuing Operations	9.35	12	28	17	21	60	128	186	36	-26
Consolidated Net Income / (Loss)	9.35	12	28	17	21	60	128	186	36	-26
Depreciation Expense	4.59	5.33	11	16	21	27	38	51	69	70
Amortization Expense	-	2.27	3.98	4.25	7.54	11	22	1.82	2.45	16
Non-Cash Adjustments To Reconcile Net Income	3.60	0.50	6.81	7.59	16	13	30	33	57	68
Changes in Operating Assets and Liabilities, net	-2.49	-12	-32	-11	-0.73	-53	-100	-100	-49	47
Net Cash From Investing Activities	4.79	-49	-99	-14	-205	-201	-221	-233	-123	-86
Net Cash From Continuing Investing Activities	4.79	-49	-99	-14	-205	-201	-221	-233	-123	-86
Purchase of Property, Plant & Equipment	-2.63	-4.33	-5.45	-12	-19	-22	-67	-85	-36	-26
Acquisitions	-	-45	-113	-2.15	-187	-179	-154	-49	-189	-62
Purchase of Investments	-20	-24	-0.05	-	-	0.00	0.00	-100	0.00	0.00
Sale and/or Maturity of Investments	28	23	20	-	-	-	0.00	0.00	102	0.00
Other Investing Activities, net	-	-	-	-	-	0.00	0.00	0.11	0.03	1.29
Net Cash From Financing Activities	0.77	112	130	3.41	485	306	0.96	-13	249	-83
Net Cash From Continuing Financing Activities	0.77	112	130	3.41	485	306	0.96	-13	249	-83
Repayment of Debt	-	-	-	-0.01	-115	0.00	-0.02	-0.03	-7.30	-70
Repurchase of Common Equity	-	-	-	-	-	-	0.00	0.00	-14	0.00
Issuance of Debt	-	111	-	0.00	278	-	0.00	0.00	290	0.00
Other Financing Activities, net	0.87	1.84	0.64	3.42	0.68	8.14	0.98	-13	-19	-13
Effect of Exchange Rate Changes	-1.88	-2.30	2.38	-2.08	-3.19	13	-12	-5.87	-12	-0.08
Cash Interest Paid	-	1.22	2.44	2.44	1.48	1.07	1.07	1.03	0.99	6.07
Cash Income Taxes Paid	4.95	3.99	4.02	4.05	6.51	10	17	34	27	19

This table details how cash moves in and out of Repligen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-23	-50	-6.85	87	27	121	29	29	-25	-27
Net Cash From Operating Activities	41	62	11	34	39	29	45	42	49	39
Net Cash From Continuing Operating Activities	41	62	11	34	39	29	45	42	49	39
Net Income / (Loss) Continuing Operations	40	49	15	6.29	3.15	-16	3.30	6.92	2.94	-34
Consolidated Net Income / (Loss)	40	49	15	6.29	3.15	-16	3.30	6.92	2.94	-34
Depreciation Expense	13	14	15	16	20	17	17	17	18	18
Amortization Expense	0.46	0.46	0.46	6.94	0.46	1.08	3.81	13	17	-8.79
Non-Cash Adjustments To Reconcile Net Income	9.28	6.31	9.88	1.82	11	28	13	30	40	27
Changes in Operating Assets and Liabilities, net	-21	-7.99	-30	3.19	4.77	-1.06	7.49	-24	-28	37
Net Cash From Investing Activities	-57	-121	-9.43	65	-8.77	-170	-8.36	-7.40	-5.86	-65
Net Cash From Continuing Investing Activities	-57	-121	-9.43	65	-8.77	-170	-8.36	-7.40	-5.86	-65
Purchase of Property, Plant & Equipment	-12	-20	-8.51	-8.24	-8.39	-11	-8.35	-4.81	-6.98	-5.54
Acquisitions	-46	-0.94	-0.92	-29	-0.41	-159	-0.03	-2.59	-0.16	-59
Net Cash From Financing Activities	1.25	-0.27	-9.56	-8.83	-0.78	268	-8.97	-5.77	-70	1.45
Net Cash From Continuing Financing Activities	1.25	-0.27	-9.56	-8.83	-0.78	268	-8.97	-5.77	-70	1.45
Other Financing Activities, net	1.25	-0.27	-9.56	-8.81	-0.74	-0.33	-8.84	-5.61	0.03	1.45
Effect of Exchange Rate Changes	-8.27	9.80	0.99	-3.43	-2.56	-6.74	1.92	-0.49	0.96	-2.47

This table presents Repligen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	146	289	744	775	1,400	1,903	2,358	2,532	2,831	2,830
Total Current Assets	103	184	243	276	642	902	932	998	1,111	1,066
Cash & Equivalents	54	122	174	194	528	717	604	523	751	757
Accounts Receivable	11	16	28	36	44	71	117	116	124	134
Inventories, net	18	25	39	42	55	95	184	238	202	143
Prepaid Expenses	2.10	1.64	2.28	3.90	5.92	19	26	20	34	32
Plant, Property, & Equipment, net	14	15	22	32	48	67	125	191	207	198
Total Noncurrent Assets	29	90	478	467	710	934	1,302	1,343	1,512	1,566
Goodwill	14	60	327	327	468	618	860	856	987	1,031
Intangible Assets	13	30	145	135	213	287	337	361	407	398
Noncurrent Deferred & Refundable Income Taxes	-	-	0.00	4.36	2.92	2.48	1.90	0.84	1.53	0.75
Other Noncurrent Operating Assets	-	-	6.23	0.17	26	26	102	126	117	136
Total Liabilities & Shareholders' Equity	146	289	744	775	1,400	1,903	2,358	2,532	2,831	2,830
Total Liabilities	23	120	152	159	340	374	608	621	866	857
Total Current Liabilities	19	21	25	130	48	319	375	404	165	127
Short-Term Debt	-	-	0.00	103	0.00	244	255	299	82	17
Accounts Payable	6.72	5.06	7.28	10	11	17	36	28	20	32
Accrued Expenses	12	16	18	16	33	53	75	71	57	62
Other Current Liabilities	-	-	-	-	3.56	5.25	8.30	6.96	5.63	15
Total Noncurrent Liabilities	4.71	99	127	29	292	55	233	217	701	730
Long-Term Debt	-	95	99	-	233	-	-	0.00	510	526
Noncurrent Deferred & Payable Income Tax Liabilities	-	2.10	25	25	30	27	33	23	39	23
Other Noncurrent Operating Liabilities	4.71	1.70	2.34	4.13	29	28	200	194	152	182
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973
Total Preferred & Common Equity	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	123	169	592	616	1,060	1,529	1,750	1,911	1,965	1,973
Common Stock	203	242	629	643	1,069	1,461	1,573	1,548	1,570	1,618
Retained Earnings	-72	-60	-32	-16	5.84	66	194	397	433	407
Accumulated Other Comprehensive Income / (Loss)	-8.57	-14	-6.36	-12	-15	2.09	-17	-34	-38	-53

This table presents Repligen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	2,463	2,548	2,557	2,523	2,854	2,866	2,831
Total Current Assets	953	1,022	1,000	980	1,131	1,157	1,132
Cash & Equivalents	573	517	604	631	781	809	784
Accounts Receivable	118	133	120	106	116	123	129
Inventories, net	243	245	241	211	198	191	182
Prepaid Expenses	20	25	35	32	36	33	36
Plant, Property, & Equipment, net	174	193	203	202	206	205	203
Total Noncurrent Assets	1,335	1,334	1,355	1,341	1,517	1,505	1,496
Goodwill	851	856	871	869	986	986	988
Intangible Assets	360	353	358	350	394	386	381
Noncurrent Deferred & Refundable Income Taxes	1.76	0.85	1.76	1.55	0.87	0.68	0.10
Other Noncurrent Operating Assets	122	123	124	120	136	132	128
Total Liabilities & Shareholders' Equity	2,463	2,548	2,557	2,523	2,854	2,866	2,831
Total Liabilities	627	621	600	549	888	882	814
Total Current Liabilities	411	417	388	379	182	175	108
Short-Term Debt	298	313	302	299	94	83	14
Accounts Payable	25	26	24	19	19	21	21
Accrued Expenses	75	69	60	58	59	58	61
Other Current Liabilities	13	7.96	2.89	3.32	9.78	12	12
Total Noncurrent Liabilities	217	205	212	170	707	707	706
Long-Term Debt	-	-	-	-	514	518	522
Noncurrent Deferred & Payable Income Tax Liabilities	23	22	22	15	37	34	34
Other Noncurrent Operating Liabilities	193	182	190	156	156	155	150
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,835	1,927	1,957	1,974	1,966	1,984	2,017
Total Preferred & Common Equity	1,835	1,927	1,957	1,974	1,966	1,984	2,017
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,835	1,927	1,957	1,974	1,966	1,984	2,017
Common Stock	1,542	1,546	1,562	1,568	1,572	1,587	1,610
Retained Earnings	349	413	432	449	436	442	441
Accumulated Other Comprehensive Income / (Loss)	-55	-31	-37	-43	-43	-44	-35

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	31.46%	150.17%	-32.42%	37.38%	39.28%	35.53%	83.08%	19.54%	-21.11%	0.33%
EBITDA Growth	20.23%	26.85%	22.36%	66.45%	38.67%	65.62%	111.87%	18.18%	-55.38%	-63.68%
EBIT Growth	22.43%	13.48%	-11.88%	97.10%	36.26%	90.79%	141.26%	29.57%	-77.62%	-188.23%
NOPAT Growth	22.19%	66.54%	243.29%	-63.23%	46.65%	139.18%	97.77%	36.43%	-84.29%	-182.09%
Net Income Growth	14.38%	25.00%	142.73%	-41.39%	28.85%	179.88%	114.08%	44.95%	-80.86%	-171.68%
EPS Growth	12.00%	21.43%	111.76%	-48.61%	18.92%	152.27%	101.80%	44.64%	-80.56%	-173.02%
Operating Cash Flow Growth	-18.19%	-50.04%	132.03%	87.78%	105.11%	-6.83%	90.05%	44.59%	-33.80%	53.97%
Free Cash Flow Firm Growth	186.01%	-671.25%	-497.74%	103.51%	-1,776.49%	-14.70%	10.28%	103.23%	-2,964.87%	112.31%
Invested Capital Growth	-0.79%	149.14%	324.48%	1.59%	43.77%	39.79%	32.77%	13.13%	13.91%	-2.66%
Revenue Q/Q Growth	6.44%	108.17%	-38.50%	-15.08%	29.98%	11.98%	13.14%	0.03%	-5.59%	2.99%
EBITDA Q/Q Growth	6.25%	24.59%	11.23%	11.42%	2.12%	13.21%	17.80%	1.26%	-31.04%	-50.03%
EBIT Q/Q Growth	7.80%	14.08%	0.75%	22.40%	-6.10%	18.94%	13.66%	6.48%	-54.40%	-481.76%
NOPAT Q/Q Growth	11.04%	80.16%	37.53%	-34.48%	-5.01%	34.90%	6.56%	8.03%	-68.48%	-590.68%
Net Income Q/Q Growth	7.64%	68.87%	33.72%	-28.25%	-8.67%	36.72%	7.92%	11.79%	-68.92%	-30.99%
EPS Q/Q Growth	3.70%	78.95%	22.03%	-28.85%	-12.00%	35.37%	6.67%	11.72%	-68.50%	-39.39%
Operating Cash Flow Q/Q Growth	11.88%	-15.67%	316.79%	-22.77%	22.00%	-4.28%	41.24%	7.67%	-22.36%	6.12%
Free Cash Flow Firm Q/Q Growth	21.51%	-154.90%	13.48%	-55.98%	1.40%	-3,065.94%	48.82%	118.27%	-9,817.70%	120.32%
Invested Capital Q/Q Growth	-3.14%	49.13%	0.40%	1.28%	0.30%	29.92%	4.09%	1.67%	9.04%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	57.80%	77.45%	52.53%	55.40%	55.93%	57.23%	58.35%	56.85%	44.03%	43.29%
EBITDA Margin	21.44%	10.87%	19.68%	23.85%	23.75%	29.02%	33.58%	33.20%	18.78%	6.80%
Operating Margin	16.48%	7.64%	9.92%	13.39%	13.35%	19.06%	24.94%	28.03%	7.54%	-5.53%
EBIT Margin	15.94%	7.23%	9.43%	13.53%	13.24%	18.63%	24.55%	26.61%	7.55%	-6.64%
Profit (Net Income) Margin	11.19%	5.59%	20.07%	8.56%	7.92%	16.36%	19.13%	23.20%	5.63%	-4.02%
Tax Burden Percent	69.62%	99.91%	391.18%	77.52%	81.87%	101.20%	83.55%	84.86%	62.77%	94.37%
Interest Burden Percent	100.78%	77.36%	54.42%	81.66%	73.11%	86.77%	93.26%	102.73%	118.76%	64.17%
Effective Tax Rate	30.38%	0.09%	-291.18%	22.48%	18.13%	-1.20%	16.45%	15.14%	37.23%	0.00%
Return on Invested Capital (ROIC)	19.52%	18.70%	17.15%	3.87%	4.61%	7.80%	11.37%	12.77%	1.77%	-1.38%
ROIC Less NNEP Spread (ROIC-NNEP)	19.87%	25.78%	60.67%	8.15%	8.73%	10.56%	14.16%	14.16%	-0.57%	-0.88%
Return on Net Nonoperating Assets (RNNOA)	-11.55%	-10.68%	-9.69%	-1.11%	-2.06%	-3.18%	-3.55%	-2.61%	0.07%	0.08%
Return on Equity (ROE)	7.97%	8.01%	7.46%	2.75%	2.56%	4.63%	7.82%	10.16%	1.84%	-1.30%
Cash Return on Invested Capital (CROIC)	20.31%	-66.73%	-106.58%	2.29%	-31.30%	-25.38%	-16.78%	0.45%	-11.24%	1.32%
Operating Return on Assets (OROA)	9.70%	6.95%	2.58%	3.46%	3.29%	4.13%	7.73%	8.73%	1.78%	-1.49%
Return on Assets (ROA)	6.81%	5.37%	5.49%	2.19%	1.97%	3.63%	6.02%	7.61%	1.33%	-0.90%
Return on Common Equity (ROCE)	7.97%	8.01%	7.46%	2.75%	2.56%	4.63%	7.82%	10.16%	1.84%	-1.30%
Return on Equity Simple (ROE_SIMPLE)	7.61%	6.92%	4.79%	2.70%	2.02%	3.92%	7.33%	9.73%	1.81%	-1.29%
Net Operating Profit after Tax (NOPAT)	9.58	16	55	20	30	71	140	191	30	-25
NOPAT Margin	11.47%	7.64%	38.79%	10.38%	10.93%	19.29%	20.84%	23.79%	4.74%	-3.87%
Net Nonoperating Expense Percent (NNEP)	-0.35%	-7.08%	-43.52%	-4.28%	-4.12%	-2.76%	-2.79%	-1.39%	2.34%	-0.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.63%	1.17%	-0.98%
Cost of Revenue to Revenue	42.20%	22.55%	47.47%	44.60%	44.07%	42.77%	41.65%	43.15%	55.97%	56.71%
SG&A Expenses to Revenue	29.57%	14.76%	36.47%	33.86%	35.38%	32.66%	27.42%	26.93%	34.57%	41.51%
R&D to Revenue	6.87%	3.52%	6.14%	8.15%	7.20%	5.51%	5.11%	5.48%	6.76%	6.81%
Operating Expenses to Revenue	41.33%	-30.14%	42.61%	42.01%	42.58%	38.17%	33.41%	28.82%	36.49%	48.82%
Earnings before Interest and Taxes (EBIT)	13	15	13	26	36	68	165	213	48	-42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	18	23	28	46	64	106	225	266	119	43
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.59	6.18	2.67	3.76	4.54	6.59	8.37	4.92	5.11	4.09
Price to Tangible Book Value (P/TBV)	9.74	13.13	13.23	15.08	12.71	16.17	26.51	13.53	17.59	14.83
Price to Revenue (P/Rev)	11.16	4.99	11.19	11.92	17.82	27.53	21.84	11.73	15.87	12.71
Price to Earnings (P/E)	99.73	4.73	55.75	139.20	224.91	168.26	114.14	50.55	282.01	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.00%	21.15%	1.79%	0.72%	0.44%	0.59%	0.88%	1.98%	0.35%	0.00%
Enterprise Value to Invested Capital (EV/IC)	17.56	8.18	2.91	4.23	5.97	9.10	10.20	5.72	5.47	4.47
Enterprise Value to Revenue (EV/Rev)	10.28	4.77	10.66	11.46	16.69	26.24	21.32	11.32	15.62	12.37
Enterprise Value to EBITDA (EV/EBITDA)	47.93	43.84	54.17	48.03	70.29	90.42	63.48	34.10	83.20	182.00
Enterprise Value to EBIT (EV/EBIT)	64.46	65.91	113.08	84.68	126.11	140.82	86.82	42.54	206.90	0.00
Enterprise Value to NOPAT (EV/NOPAT)	89.60	62.42	27.49	110.34	152.69	136.00	102.29	47.60	329.94	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	57.04	132.45	86.30	67.83	67.11	153.45	120.10	52.74	86.73	44.76
Enterprise Value to Free Cash Flow (EV/FCFF)	86.11	0.00	0.00	186.00	0.00	0.00	0.00	1,363.80	0.00	334.54
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.56	0.17	0.17	0.22	0.16	0.15	0.16	0.30	0.28
Long-Term Debt to Equity	0.00	0.56	0.17	0.00	0.22	0.00	0.00	0.00	0.26	0.27
Financial Leverage	-0.58	-0.41	-0.16	-0.14	-0.24	-0.30	-0.25	-0.18	-0.12	-0.09
Leverage Ratio	1.17	1.49	1.36	1.26	1.30	1.28	1.30	1.34	1.38	1.44
Compound Leverage Factor	1.18	1.15	0.74	1.03	0.95	1.11	1.21	1.37	1.64	0.92
Debt to Total Capital	0.00%	36.08%	14.37%	14.39%	18.01%	13.75%	12.73%	13.51%	23.17%	21.57%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	14.39%	0.00%	13.75%	12.73%	13.51%	3.22%	0.68%
Long-Term Debt to Total Capital	0.00%	36.08%	14.37%	0.00%	18.01%	0.00%	0.00%	0.00%	19.95%	20.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	63.92%	85.63%	85.61%	81.99%	86.25%	87.27%	86.49%	76.83%	78.43%
Debt to EBITDA	0.00	4.19	3.57	2.24	3.63	2.29	1.13	1.12	4.99	12.58
Net Debt to EBITDA	0.00	-2.05	-2.68	-1.95	-4.75	-4.46	-1.55	-1.22	-1.34	-4.98
Long-Term Debt to EBITDA	0.00	4.19	3.57	0.00	3.63	0.00	0.00	0.00	4.30	12.19
Debt to NOPAT	0.00	5.97	1.81	5.14	7.88	3.45	1.83	1.57	19.79	-22.08
Net Debt to NOPAT	0.00	-2.91	-1.36	-4.48	-10.31	-6.70	-2.49	-1.71	-5.30	8.73
Long-Term Debt to NOPAT	0.00	5.97	1.81	0.00	7.88	0.00	0.00	0.00	17.04	-21.38
Altman Z-Score	24.69	6.49	6.78	9.29	9.28	16.92	15.36	10.18	7.85	6.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.50	8.74	9.63	2.12	13.28	2.83	2.48	2.47	6.74	8.41
Quick Ratio	4.43	7.49	7.99	1.77	11.84	2.47	1.92	1.83	5.31	7.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	9.97	-57	-340	12	-200	-230	-206	6.65	-191	23
Operating Cash Flow to CapEx	572.79%	175.72%	319.97%	275.61%	363.25%	278.89%	177.40%	202.85%	314.50%	683.08%
Free Cash Flow to Firm to Interest Expense	311.58	-15.12	-52.86	1.78	-13.41	-21.34	-18.28	5.73	-12.56	1.13
Operating Cash Flow to Interest Expense	470.41	2.00	2.71	4.88	4.50	5.82	10.55	148.09	7.51	8.46
Operating Cash Flow Less CapEx to Interest Expense	388.28	0.86	1.86	3.11	3.26	3.73	4.60	75.09	5.12	7.22
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.61	0.96	0.27	0.26	0.25	0.22	0.31	0.33	0.24	0.22
Accounts Receivable Turnover	8.62	15.25	6.45	6.11	6.81	6.37	7.10	6.86	5.26	4.91
Inventory Turnover	2.32	2.21	2.11	2.13	2.45	2.09	2.00	1.64	1.61	2.08
Fixed Asset Turnover	5.90	14.53	7.56	7.11	6.70	6.35	6.99	5.08	3.18	3.13
Accounts Payable Turnover	6.66	8.00	10.86	9.74	10.87	11.07	10.52	10.85	15.02	13.92
Days Sales Outstanding (DSO)	42.34	23.94	56.56	59.72	53.64	57.33	51.39	53.20	69.38	74.29
Days Inventory Outstanding (DIO)	157.29	165.37	173.38	171.40	148.78	174.60	182.66	223.10	227.19	175.14
Days Payable Outstanding (DPO)	54.81	45.65	33.60	37.48	33.58	32.98	34.69	33.65	24.30	26.22
Cash Conversion Cycle (CCC)	144.82	143.66	196.35	193.64	168.84	198.96	199.36	242.66	272.28	223.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	49	122	517	525	755	1,056	1,402	1,586	1,806	1,758
Invested Capital Turnover	1.70	2.45	0.44	0.37	0.42	0.40	0.55	0.54	0.37	0.36
Increase / (Decrease) in Invested Capital	-0.39	73	395	8.20	230	300	346	184	221	-48
Enterprise Value (EV)	859	996	1,506	2,223	4,511	9,610	14,294	9,076	9,880	7,850
Market Capitalization	932	1,043	1,581	2,313	4,815	10,083	14,643	9,401	10,039	8,064
Book Value per Share	$3.73	$4.99	$13.58	$14.04	$20.36	$29.06	$31.65	$34.41	$35.19	$35.21
Tangible Book Value per Share	$2.90	$2.35	$2.74	$3.50	$7.28	$11.85	$9.99	$12.51	$10.22	$9.71
Total Capital	123	264	691	719	1,293	1,773	2,005	2,209	2,557	2,515
Total Debt	0.00	95	99	103	233	244	255	299	593	543
Total Long-Term Debt	0.00	95	99	0.00	233	0.00	0.00	0.00	510	526
Net Debt	-73	-47	-75	-90	-305	-474	-349	-325	-159	-215
Capital Expenditures (CapEx)	2.63	4.28	5.45	12	19	22	67	85	36	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	21	44	56	56	110	208	269	278	199
Debt-free Net Working Capital (DFNWC)	84	163	218	249	594	827	812	892	1,029	956
Net Working Capital (NWC)	84	163	218	146	594	583	556	594	946	939
Net Nonoperating Expense (NNE)	0.24	4.28	26	3.53	8.13	11	11	4.69	-5.65	0.93
Net Nonoperating Obligations (NNO)	-74	-47	-75	-90	-305	-474	-349	-325	-159	-215
Total Depreciation and Amortization (D&A)	4.59	7.61	14	20	28	38	61	53	71	85
Debt-free, Cash-free Net Working Capital to Revenue	15.20%	10.19%	31.02%	28.64%	20.76%	30.00%	31.00%	33.53%	43.89%	31.37%
Debt-free Net Working Capital to Revenue	101.12%	78.03%	154.05%	128.53%	219.62%	225.84%	121.05%	111.35%	162.70%	150.74%
Net Working Capital to Revenue	101.12%	78.03%	154.05%	75.19%	219.62%	159.29%	82.98%	74.10%	149.66%	148.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.28	$0.35	$0.74	$0.38	$0.44	$1.14	$2.33	$3.35	$0.00	($0.46)
Adjusted Weighted Average Basic Shares Outstanding	32.88M	33.57M	38.23M	43.77M	48.34M	52.55M	55.02M	55.46M	0.00	55.94M
Adjusted Diluted Earnings per Share	$0.28	$0.34	$0.72	$0.37	$0.44	$1.11	$2.24	$3.24	$0.00	($0.46)
Adjusted Weighted Average Diluted Shares Outstanding	33.58M	34.10M	39.15M	45.47M	49.21M	53.89M	57.26M	57.46M	0.00	55.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	33.03M	33.85M	43.59M	43.92M	52.08M	54.77M	55.33M	55.56M	0.00	56.15M
Normalized Net Operating Profit after Tax (NOPAT)	12	19	9.80	20	30	49	145	166	11	-22
Normalized NOPAT Margin	14.87%	9.19%	6.94%	10.38%	10.93%	13.34%	21.57%	20.74%	1.70%	-3.52%
Pre Tax Income Margin	16.07%	5.59%	5.13%	11.05%	9.68%	16.17%	22.90%	27.34%	8.97%	-4.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	416.22	4.01	2.07	3.91	2.39	6.34	14.60	183.58	3.15	-2.03
NOPAT to Interest Expense	299.45	4.24	8.51	3.00	1.98	6.56	12.39	164.07	1.97	-1.19
EBIT Less CapEx to Interest Expense	334.09	2.88	1.22	2.14	1.16	4.25	8.65	110.58	0.76	-3.27
NOPAT Less CapEx to Interest Expense	217.33	3.10	7.66	1.23	0.74	4.48	6.44	91.07	-0.41	-2.42
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.06%	6.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.06%	6.83%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	40.41%	0.00%

This table displays calculated financial ratios and metrics derived from Repligen's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.64%	0.13%	-19.87%	-23.34%	-29.66%	-10.78%	-7.38%	-0.21%	9.69%	0.56%
EBITDA Growth	2.49%	5.43%	-58.98%	-40.84%	-56.35%	-56.10%	-30.22%	-18.95%	13.68%	-213.26%
EBIT Growth	2.73%	35.78%	-77.21%	-67.38%	-88.76%	-80.11%	-102.00%	-75.54%	-200.59%	-523.11%
NOPAT Growth	22.10%	43.64%	-76.05%	-70.94%	-84.44%	-293.89%	-70.80%	-77.40%	-178.60%	70.66%
Net Income Growth	20.62%	67.40%	-67.34%	-60.32%	-58.12%	-133.76%	-78.51%	-71.13%	-103.86%	-105.89%
EPS Growth	22.41%	68.00%	-66.67%	-60.23%	-57.75%	-134.52%	-77.78%	-71.43%	-103.33%	-110.34%
Operating Cash Flow Growth	83.99%	24.71%	-51.74%	-24.61%	-5.16%	-53.03%	300.82%	22.40%	25.72%	34.79%
Free Cash Flow Firm Growth	66.20%	55.80%	66.81%	61.58%	46.49%	-121.22%	-42.13%	10.21%	-30.55%	107.31%
Invested Capital Growth	15.81%	13.13%	8.63%	9.64%	6.22%	13.91%	10.49%	7.27%	6.76%	-2.66%
Revenue Q/Q Growth	-3.32%	-6.96%	-11.45%	-12.86%	-11.29%	18.01%	-1.64%	4.95%	0.52%	8.18%
EBITDA Q/Q Growth	-18.26%	9.07%	-54.26%	-8.73%	-28.59%	9.69%	18.53%	85.15%	35.42%	-209.30%
EBIT Q/Q Growth	-23.10%	7.94%	-72.63%	-37.32%	-73.67%	91.03%	72.15%	338.13%	-785.77%	-703.55%
NOPAT Q/Q Growth	-14.95%	0.19%	-74.50%	-38.65%	-54.91%	-1,348.46%	638.74%	72.05%	-675.29%	-366.05%
Net Income Q/Q Growth	-18.96%	20.60%	-68.53%	-31.37%	-15.65%	-197.21%	112.93%	172.83%	-119.69%	-5,078.75%
EPS Q/Q Growth	-19.32%	18.31%	-67.86%	-31.37%	-14.29%	-196.67%	113.64%	150.00%	-116.67%	-6,000.00%
Operating Cash Flow Q/Q Growth	-9.52%	49.59%	-81.98%	209.02%	13.82%	-25.91%	53.82%	-5.63%	16.90%	-20.57%
Free Cash Flow Firm Q/Q Growth	50.38%	17.25%	15.64%	-10.68%	37.57%	-242.07%	26.72%	26.65%	-9.50%	119.16%
Invested Capital Q/Q Growth	3.30%	1.67%	2.28%	1.21%	-0.77%	9.04%	-1.14%	-1.19%	-0.51%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.90%	51.44%	50.51%	50.17%	25.89%	47.10%	50.13%	51.33%	50.03%	23.18%
EBITDA Margin	29.26%	34.31%	17.72%	26.71%	18.16%	16.88%	13.35%	21.70%	18.82%	-19.02%
Operating Margin	26.24%	26.15%	8.38%	12.11%	3.32%	5.93%	2.45%	3.44%	-5.06%	-21.79%
EBIT Margin	22.73%	26.37%	8.15%	12.16%	3.63%	5.88%	-0.18%	2.98%	-3.33%	-24.73%
Profit (Net Income) Margin	20.13%	26.09%	9.27%	12.43%	11.99%	-9.87%	2.15%	3.60%	-0.42%	-20.21%
Tax Burden Percent	85.12%	91.97%	82.65%	79.45%	148.70%	-882.04%	89.20%	63.29%	56.92%	87.73%
Interest Burden Percent	104.05%	107.61%	137.68%	128.69%	221.98%	19.04%	-1,373.61%	190.68%	22.28%	93.17%
Effective Tax Rate	14.88%	8.03%	17.35%	20.55%	-48.70%	982.04%	10.80%	36.71%	0.00%	0.00%
Return on Invested Capital (ROIC)	12.32%	12.91%	3.38%	4.44%	2.06%	-19.49%	0.80%	0.77%	-1.27%	-5.43%
ROIC Less NNEP Spread (ROIC-NNEP)	13.69%	11.77%	2.04%	2.94%	-1.21%	-48.68%	0.82%	-0.11%	-2.94%	-0.97%
Return on Net Nonoperating Assets (RNNOA)	-2.48%	-2.17%	-0.32%	-0.47%	0.19%	6.08%	-0.10%	0.01%	0.43%	0.09%
Return on Equity (ROE)	9.83%	10.74%	3.06%	3.97%	2.25%	-13.41%	0.70%	0.79%	-0.85%	-5.34%
Cash Return on Invested Capital (CROIC)	-2.51%	0.45%	1.63%	-1.00%	-0.12%	-11.24%	-8.41%	-6.98%	-6.75%	1.32%
Operating Return on Assets (OROA)	7.74%	8.64%	2.51%	3.55%	0.98%	1.39%	-0.04%	0.67%	-0.77%	-5.54%
Return on Assets (ROA)	6.86%	8.55%	2.86%	3.63%	3.23%	-2.33%	0.50%	0.81%	-0.10%	-4.53%
Return on Common Equity (ROCE)	9.83%	10.74%	3.06%	3.97%	2.25%	-13.41%	0.70%	0.79%	-0.85%	-5.34%
Return on Equity Simple (ROE_SIMPLE)	9.06%	0.00%	8.01%	7.04%	5.76%	0.00%	1.50%	0.04%	-0.97%	0.00%
Net Operating Profit after Tax (NOPAT)	45	45	11	15	6.98	-87	3.35	3.46	-5.48	-26
NOPAT Margin	22.33%	24.05%	6.93%	9.62%	4.94%	-52.26%	2.18%	2.18%	-3.54%	-15.25%
Net Nonoperating Expense Percent (NNEP)	-1.37%	1.13%	1.34%	1.50%	3.27%	29.19%	-0.02%	0.88%	1.66%	-4.46%
Return On Investment Capital (ROIC_SIMPLE)	-	2.03%	-	-	-	-3.41%	-	-	-	-1.02%
Cost of Revenue to Revenue	43.10%	48.56%	49.49%	49.83%	74.11%	52.90%	49.87%	48.67%	49.97%	76.82%
SG&A Expenses to Revenue	26.72%	28.51%	34.04%	30.84%	39.37%	34.59%	40.35%	41.22%	48.82%	36.09%
R&D to Revenue	5.10%	5.95%	7.35%	6.10%	7.49%	6.17%	7.34%	6.66%	6.27%	6.97%
Operating Expenses to Revenue	30.67%	25.29%	42.13%	38.06%	22.57%	41.18%	47.68%	47.88%	55.09%	44.97%
Earnings before Interest and Taxes (EBIT)	46	49	13	19	5.13	9.79	-0.27	4.73	-5.16	-41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	59	64	29	43	26	28	20	34	29	-32
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.66	4.92	4.86	4.03	4.46	5.11	5.22	3.55	4.13	4.09
Price to Tangible Book Value (P/TBV)	16.64	13.53	13.05	10.82	11.43	17.59	17.55	11.49	12.86	14.83
Price to Revenue (P/Rev)	12.96	11.73	12.30	10.80	13.24	15.87	16.39	11.60	13.53	12.71
Price to Earnings (P/E)	62.69	50.55	60.61	57.18	77.40	282.01	347.66	9,159.58	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.60%	1.98%	1.65%	1.75%	1.29%	0.35%	0.29%	0.01%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	6.48	5.72	5.58	4.58	5.15	5.47	5.63	3.85	4.57	4.47
Enterprise Value to Revenue (EV/Rev)	12.61	11.32	11.90	10.39	12.74	15.62	16.11	11.26	13.13	12.37
Enterprise Value to EBITDA (EV/EBITDA)	38.46	34.10	40.40	35.74	49.55	83.20	86.81	76.70	93.70	182.00
Enterprise Value to EBIT (EV/EBIT)	50.45	42.54	53.98	52.21	81.49	206.90	246.98	957.11	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	57.27	47.60	58.71	58.39	89.83	329.94	378.73	10,997.55	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	63.24	52.74	56.52	50.88	58.16	86.73	68.46	44.05	48.93	44.76
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1,363.80	357.07	0.00	0.00	0.00	0.00	0.00	0.00	334.54
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.16	0.16	0.16	0.15	0.15	0.30	0.31	0.30	0.27	0.28
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.26	0.26	0.26	0.26	0.27
Financial Leverage	-0.18	-0.18	-0.16	-0.16	-0.16	-0.12	-0.12	-0.13	-0.15	-0.09
Leverage Ratio	1.32	1.34	1.34	1.33	1.30	1.38	1.39	1.38	1.33	1.44
Compound Leverage Factor	1.38	1.44	1.84	1.71	2.89	0.26	-19.06	2.62	0.30	1.34
Debt to Total Capital	13.96%	13.51%	13.97%	13.37%	13.05%	23.17%	23.62%	23.25%	20.98%	21.57%
Short-Term Debt to Total Capital	13.96%	13.51%	13.97%	13.37%	13.05%	3.22%	3.65%	3.23%	0.55%	0.68%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	19.95%	19.97%	20.02%	20.44%	20.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.04%	86.49%	86.03%	86.63%	86.95%	76.83%	76.38%	76.75%	79.02%	78.43%
Debt to EBITDA	1.13	1.12	1.40	1.42	1.73	4.99	5.23	6.74	6.21	12.58
Net Debt to EBITDA	-1.05	-1.22	-1.36	-1.42	-1.93	-1.34	-1.49	-2.33	-2.88	-4.98
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	4.30	4.42	5.81	6.04	12.19
Debt to NOPAT	1.69	1.57	2.03	2.33	3.14	19.79	22.80	967.14	-150.48	-22.08
Net Debt to NOPAT	-1.56	-1.71	-1.98	-2.33	-3.50	-5.30	-6.48	-334.64	69.80	8.73
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	17.04	19.28	832.94	-146.57	-21.38
Altman Z-Score	10.78	9.97	9.86	8.71	10.95	7.80	7.77	5.64	7.01	6.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.32	2.47	2.45	2.57	2.69	6.74	6.23	6.62	10.44	8.41
Quick Ratio	1.68	1.83	1.80	1.86	2.03	5.31	4.94	5.33	8.43	7.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-168	-139	-117	-130	-90	-308	-167	-117	-117	22
Operating Cash Flow to CapEx	350.15%	302.69%	131.08%	418.30%	467.82%	262.15%	535.68%	877.50%	706.29%	707.15%
Free Cash Flow to Firm to Interest Expense	-510.89	-515.12	-287.57	-316.69	-220.46	-22.05	-33.16	-22.84	-22.93	4.12
Operating Cash Flow to Interest Expense	125.74	229.19	27.34	83.86	96.15	2.08	8.89	8.24	9.63	7.17
Operating Cash Flow Less CapEx to Interest Expense	89.83	153.47	6.48	63.82	75.60	1.29	7.23	7.30	8.27	6.16
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.34	0.33	0.31	0.29	0.27	0.24	0.23	0.22	0.23	0.22
Accounts Receivable Turnover	6.69	6.86	5.94	6.04	5.99	5.26	5.03	4.99	5.24	4.91
Inventory Turnover	1.69	1.64	1.51	1.41	1.57	1.61	1.57	1.61	1.62	2.08
Fixed Asset Turnover	5.85	5.08	4.47	3.93	3.56	3.18	3.15	2.98	3.05	3.13
Accounts Payable Turnover	12.62	10.85	10.68	10.55	16.13	15.02	15.44	15.50	15.84	13.92
Days Sales Outstanding (DSO)	54.59	53.20	61.41	60.39	60.98	69.38	72.60	73.21	69.67	74.29
Days Inventory Outstanding (DIO)	215.88	223.10	242.30	258.88	232.46	227.19	231.87	227.23	225.16	175.14
Days Payable Outstanding (DPO)	28.93	33.65	34.18	34.61	22.63	24.30	23.64	23.54	23.05	26.22
Cash Conversion Cycle (CCC)	241.55	242.66	269.53	284.67	270.80	272.28	280.83	276.90	271.78	223.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,559	1,586	1,622	1,655	1,656	1,806	1,792	1,775	1,768	1,758
Invested Capital Turnover	0.55	0.54	0.49	0.46	0.42	0.37	0.37	0.35	0.36	0.36
Increase / (Decrease) in Invested Capital	213	184	129	145	97	221	170	120	112	-48
Enterprise Value (EV)	10,107	9,076	9,049	7,575	8,534	9,880	10,096	6,836	8,086	7,850
Market Capitalization	10,383	9,401	9,355	7,876	8,866	10,039	10,269	7,044	8,335	8,064
Book Value per Share	$33.07	$34.41	$34.68	$35.14	$35.67	$35.19	$35.23	$35.52	$36.01	$35.21
Tangible Book Value per Share	$11.25	$12.51	$12.90	$13.07	$13.91	$10.22	$10.49	$10.97	$11.58	$9.71
Total Capital	2,133	2,209	2,240	2,259	2,287	2,557	2,573	2,586	2,552	2,515
Total Debt	298	299	313	302	299	593	608	601	536	543
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	510	514	518	522	526
Net Debt	-276	-325	-305	-302	-332	-159	-173	-208	-248	-215
Capital Expenditures (CapEx)	12	20	8.51	8.24	8.39	11	8.35	4.81	6.98	5.54
Debt-free, Cash-free Net Working Capital (DFCFNWC)	267	269	300	310	283	278	263	256	253	199
Debt-free Net Working Capital (DFNWC)	840	892	918	913	914	1,029	1,043	1,065	1,037	956
Net Working Capital (NWC)	543	594	605	612	615	946	950	982	1,023	939
Net Nonoperating Expense (NNE)	4.42	-3.82	-3.88	-4.47	-9.95	-71	0.05	-2.25	-4.83	8.32
Net Nonoperating Obligations (NNO)	-276	-325	-305	-302	-332	-159	-174	-209	-248	-215
Total Depreciation and Amortization (D&A)	13	15	16	23	21	18	21	30	34	9.58
Debt-free, Cash-free Net Working Capital to Revenue	33.30%	33.53%	39.45%	42.48%	42.23%	43.89%	41.94%	42.20%	41.10%	31.37%
Debt-free Net Working Capital to Revenue	104.85%	111.35%	120.71%	125.25%	136.41%	162.70%	166.52%	175.48%	168.36%	150.74%
Net Working Capital to Revenue	67.71%	74.10%	79.57%	83.86%	91.83%	149.66%	151.55%	161.74%	166.10%	148.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.73	$0.87	$0.00	$0.00	$0.33	($0.30)	$0.06	$0.10	($0.01)	($0.61)
Adjusted Weighted Average Basic Shares Outstanding	55.50M	55.46M	0.00	0.00	55.77M	55.72M	55.79M	55.88M	56.01K	55.94M
Adjusted Diluted Earnings per Share	$0.71	$0.84	$0.00	$0.00	$0.32	($0.29)	$0.06	$0.10	($0.01)	($0.61)
Adjusted Weighted Average Diluted Shares Outstanding	57.30M	57.46M	0.00	0.00	56.94M	56.38M	56.53M	56.43M	56.01K	55.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.52M	55.56M	0.00	0.00	55.83M	55.77M	55.88M	56.01M	56.03M	56.15M
Normalized Net Operating Profit after Tax (NOPAT)	43	29	12	17	-21	7.40	3.35	3.46	-5.48	-23
Normalized NOPAT Margin	21.35%	15.62%	7.54%	10.52%	-14.68%	4.44%	2.18%	2.18%	-3.54%	-13.92%
Pre Tax Income Margin	23.65%	28.37%	11.22%	15.65%	8.06%	1.12%	2.41%	5.68%	-0.74%	-23.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	138.66	182.37	33.03	47.09	12.57	0.70	-0.05	0.93	-1.01	-7.59
NOPAT to Interest Expense	136.26	166.35	28.07	37.27	17.10	-6.24	0.67	0.68	-1.07	-4.68
EBIT Less CapEx to Interest Expense	102.75	106.65	12.18	27.04	-7.99	-0.09	-1.71	-0.01	-2.37	-8.60
NOPAT Less CapEx to Interest Expense	100.35	90.63	7.22	17.22	-3.46	-7.04	-0.99	-0.26	-2.43	-5.69
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	40.41%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Repligen's Financials

When does Repligen's fiscal year end?

According to the most recent income statement we have on file, Repligen's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Repligen's net income changed over the last 9 years?

Repligen's net income appears to be on an upward trend, with a most recent value of -$25.51 million in 2024, falling from $9.35 million in 2015. The previous period was $35.60 million in 2023.

What is Repligen's operating income?

Repligen's total operating income in 2024 was -$35.11 million, based on the following breakdown:

Total Gross Profit: $274.65 million
Total Operating Expenses: $309.76 million

How has Repligen revenue changed over the last 9 years?

Over the last 9 years, Repligen's total revenue changed from $83.54 million in 2015 to $634.44 million in 2024, a change of 659.5%.

How much debt does Repligen have?

Repligen's total liabilities were at $856.95 million at the end of 2024, a 1.1% decrease from 2023, and a 3,548.3% increase since 2015.

How much cash does Repligen have?

In the past 9 years, Repligen's cash and equivalents has ranged from $54.09 million in 2015 to $757.36 million in 2024, and is currently $757.36 million as of their latest financial filing in 2024.

How has Repligen's book value per share changed over the last 9 years?

Over the last 9 years, Repligen's book value per share changed from 3.73 in 2015 to 35.21 in 2024, a change of 845.0%.

Remove Ads

Related Companies

This page (NASDAQ:RGEN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Repligen (RGEN) Financials

Frequently Asked Questions About Repligen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Repligen (RGEN) Financials

Annual Income Statements for Repligen

Quarterly Income Statements for Repligen

Annual Cash Flow Statements for Repligen

Quarterly Cash Flow Statements for Repligen

Annual Balance Sheets for Repligen

Quarterly Balance Sheets for Repligen

Annual Metrics and Ratios for Repligen

Quarterly Metrics and Ratios for Repligen

Frequently Asked Questions About Repligen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools